Exscientia, a world leader in artificial intelligence (“AI”) driven drug discovery and a spinout company of the University of Dundee, has made two announcements today regarding major investments and collaboration. The Company has raised US$26 million in a Series B financing round to scale up its pipeline and advance selected programmes towards clinical development. The round included participation from new investors Celgene Corporation and specialist...
A £40m investment project is set to deliver an innovation hub to double the number of life sciences companies in North East Scotland and support the national ambitions for the sector to collaborate, innovate and commercialise the next generation of therapies and healthcare solutions. The Bio-therapeutics Hub for Innovation in Aberdeen will be a focal point for sector ambition and growth and has secured £20m...
Funding will be used to improve the efficiency of induced pluripotent stem cell production. Edinburgh, UK and Glasgow, UK: ROSLINCT, a leading cell and gene therapy contract manufacturing organisation, today announced it is to receive investment to collaborate with REPROCELL Europe Ltd (REPROCELL), a UK-based stem cell company, on a £1.2million project which will develop a faster, more cost-effective method of producing clinical-grade induced pluripotent stem...
Innovate UK has awarded funding to a collaborative project to develop a new care path for patients which could save the NHS 1.4 Billion. Collaboration between NHS Greater Glasgow & Clyde, eHealth, the Department of Research & Development and Edinburgh based StormID, KenSCI and ResMed has resulted in a new project which will develop a new care pathway for patients with COPD. Chronic Obstructive Pulmonary Disease (COPD) affects 1.2 million people in...
The UK Government have chosen the University of Glasgow to lead on the Science and Innovation Audit of Precision Medicine Innovation in Scotland. The audit will help to identify opportunities for investment and growth by mapping Scotland’s research, innovation and infrastructure strengths in precision medicine. The aim is to position Scotland as one of the best places to develop precision medicine and build on international...
3f bio Ltd, a spinout company from the University of Strathclyde has secured an investment round of £461,000. 3f bio Ltd is involved in the sustainable production of food protein, at a reduced cost. The funding raised allows 3f bio Ltd to progress development of the product and increasing scale of production, as well as embarking on technological advances to global potentials for sustainable protein....